Page last updated: 2024-10-29

imipramine and Prostatic Diseases

imipramine has been researched along with Prostatic Diseases in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, S1
Pandey, D1
Mandalapu, D1
Sharma, V1
Shukla, M1
Singh, S2
Singh, N1
Yadav, SK1
Tanpula, DK1
Maikhuri, JP1
Shukla, S1
Lal, J1
Siddiqi, MI1
Gupta, G1
Sharma, VL1
Arnold, SJ1
Ginsburg, A1

Reviews

1 review available for imipramine and Prostatic Diseases

ArticleYear
Understanding and managing enuresis in children.
    Postgraduate medicine, 1975, Volume: 58, Issue:6

    Topics: Affective Symptoms; Child; Child Development; Child, Preschool; Dexamethasone; Enuresis; Female; Hum

1975

Other Studies

1 other study available for imipramine and Prostatic Diseases

ArticleYear
Novel aryl piperazines for alleviation of 'andropause' associated prostatic disorders and depression.
    European journal of medicinal chemistry, 2017, May-26, Volume: 132

    Topics: Androgen Antagonists; Andropause; Animals; Cell Line; Depression; Down-Regulation; Humans; Male; Mol

2017